Dr. James Lu co-founded population genomics company Helix in 2015, where he leads the research, regulatory policy and bioinformatics teams. He oversees the teams that develop and validate the science and technology behind Helix’s solution, including Helix’s next generation sequencing lab. Dr. Lu also works...
GenXys, a health tech company focused on pharmacogenetic enhanced prescribing automation software, is pleased to announce that it has closed an oversubscribed seed round at $3 million. Led by Green Shield Canada, (GSC), with key investors including TELUS Ventures, Esplanade Ventures, Nimbus Synergies, and the...
TreatGx has undergone some exciting changes to make it easier and faster than ever to generate personalized medication treatment options. As a result of this update, you may notice that some question categories may display as red and require you to re-input information. We’ve updated the...
